<DOC>
	<DOCNO>NCT02996851</DOCNO>
	<brief_summary>Oral antithrombotic medication ( OAM ) use prevention treatment thrombotic disorder . Among hemorrhagic complication OAMs , intracranial hemorrhage ( ICH ) may particularly devastate consequence high morbidity , disability mortality rate . The efficacy safety profile OAMs generally assess randomize control trial ( RCT ) , include patient often highly select may representative user everyday clinical practice term follow-up routine , age , gender , drug compliance , polypharmacy . Moreover , often unclear whether traumatic ICHs register report RCTs . Drifts indication treatment criterion may also see everyday practice drug discontinuation due precautionary concern include compliance , fall risk comorbidity may forget . Collectively , factor may lead potentially high traumatic ICH rate general clinical use report RCTs . The incidence rate traumatic ICH patient OAMs general population remain unknown . In nationwide registry base pharmacoepidemiological study investigate incidence case fatality traumatic ICH user OAMs Norway 2008 2014 .</brief_summary>
	<brief_title>Traumatic Intracranial Hemorrhage Users Oral Antithrombotic Drugs</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Hematoma</mesh_term>
	<mesh_term>Intracranial Hemorrhages</mesh_term>
	<mesh_term>Embolism Thrombosis</mesh_term>
	<mesh_term>Intracranial Hemorrhage , Traumatic</mesh_term>
	<mesh_term>Hematoma , Subdural</mesh_term>
	<mesh_term>Hematoma , Subdural , Intracranial</mesh_term>
	<criteria>included Norwegian patient registry ( NPR ) and/or Norwegian prescription database ( NorPD )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Fibrinolytic Agents</keyword>
	<keyword>Adverse effect</keyword>
	<keyword>Norway</keyword>
	<keyword>Registries</keyword>
</DOC>